TRIL
Trillium Therapeutics Inc.
TRIL
TRIL
Delisted
TRIL was delisted on the 16th of November, 2021.
131 hedge funds and large institutions have $1.12B invested in Trillium Therapeutics Inc. in 2020 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 57 increasing their positions, 28 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
15% more funds holding
Funds holding: 114 → 131 (+17)
15% less call options, than puts
Call options by funds: $23.6M | Put options by funds: $27.9M
Holders
131
Holding in Top 10
7
Calls
$23.6M
Puts
$27.9M
Top Buyers
| 1 | +$25.1M | |
| 2 | +$23.3M | |
| 3 | +$21.2M | |
| 4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$15.1M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$10.9M |
Top Sellers
| 1 | -$46.6M | |
| 2 | -$35.5M | |
| 3 | -$12.8M | |
| 4 |
MWNA
Marshall Wace North America
New York
|
-$8.02M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$7.76M |